Advanced therapies inspired for you

Defymed is a company that develops and markets implantable bio-artificial medical devices for diverse therapeutic applications.

Our basic aim is to develop breakthrough innovations that enhance drug delivery systems leading to improvements in the quality of life of patients.
Séverine Sigrist, Defymed CEO Who are we ?

Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life

Diabetes

Patients

500

million diabetics worldwide forecasted for 2045

Expenses

$ 750

billion per year spent on diabetes-related expenses

Treatments

more than 10

million diabetics receiving insulin therapy have poorly regulated blood glucose levels

A bio-artificial pancreas intended to be filled with insulin-secreting cells in order to regulate blood glucose levels in a more physiological way

More about MailPan ®

An insulin delivery device that makes injections of insulin more efficient

More about ExOlin ®

Team

Reinventing together health innovation

Team
Top notch network

International partnerships focused on open innovation

Top notch network
Breakthrough technologies

Your health challenges our innovation

Technologies
Service Provision

Full chain R&D facilities, combining both in vitro and in vivo assays, using well established experimental models

Service Provision
Quality

ISO-13485:2016 to guarantee the safety of our medical devices and optimize our corporate performance

Certificate